Skip to content

Clinical trials

Active, not recruiting Phase 1/2 trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Active, not recruiting Country / region: France Clear all

135 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20132
20141
20153
20167
20175
20188
201917
202019
202113
202224
20236
202419
202510
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting135

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals12
Hoffmann-La Roche8
GlaxoSmithKline7
AstraZeneca5
Celgene4
Genmab4
Merck Sharp & Dohme LLC4
Amgen3
Eli Lilly and Company3
Ipsen3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung20
Breast Neoplasms10
Colorectal Neoplasms10
Neoplasms10
Multiple Myeloma9
Neoplasm Metastasis9
Recurrence8
Squamous Cell Carcinoma of Head and Neck7
Stomach Neoplasms6
Central Nervous System Neoplasms5

Trials

Showing 1 to 25 of 135. Each trial links to its page on Pharma Observatory.

35 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.